Mercy BioAnalytics is on a mission to save lives and relieve suffering across the globe through the early detection of cancer. We have developed a novel liquid biopsy assay platform which interrogates tumor-derived extracellular vesicles, which are abundant in blood and carry information about their cell of origin, enabling detection of cancer even in at the earliest stages.
Looking for a particular Mercy BioAnalytics, Inc. employee's phone or email?
The Mercy BioAnalytics, Inc. annual revenue was $200000 in 2026.
Dawn Mattoon is the CEO of Mercy BioAnalytics, Inc..
56 people are employed at Mercy BioAnalytics, Inc..
Mercy BioAnalytics, Inc. is based in Waltham, Massachusetts.
The NAICS codes for Mercy BioAnalytics, Inc. are [54, 5417, 541713, 54171, 541].
The SIC codes for Mercy BioAnalytics, Inc. are [87, 873].